Combined Metformin and Baricitinib Therapy Attenuates Inflammation in STZ‐Induced Diabetic Rats via AMPK/JAK–STAT Pathway Crosstalk
ABSTRACT Background Chronic inflammation is a critical factor contributing to diabetes complications. Baricitinib inhibits JAK–STAT signalling, which can contribute to an anti‐inflammatory effect. Similarly, metformin demonstrates anti‐inflammatory properties by activating the AMPK–SIRT pathway and...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2025-09-01
|
| Seri Bilgileri: | Endocrinology, Diabetes & Metabolism |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/edm2.70101 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|